Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20,748 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Ulz P, Perakis S, Zhou Q, Moser T, Belic J, Lazzeri I, Wölfler A, Zebisch A, Gerger A, Pristauz G, Petru E, White B, Roberts CES, John JS, Schimek MG, Geigl JB, Bauernhofer T, Sill H, Bock C, Heitzer E, Speicher MR. Ulz P, et al. Among authors: zhou q. Nat Commun. 2019 Oct 11;10(1):4666. doi: 10.1038/s41467-019-12714-4. Nat Commun. 2019. PMID: 31604930 Free PMC article.
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Ulz P, Perakis S, Zhou Q, Moser T, Belic J, Lazzeri I, Wölfler A, Zebisch A, Gerger A, Pristauz G, Petru E, White B, Roberts CES, John JS, Schimek MG, Geigl JB, Bauernhofer T, Sill H, Bock C, Heitzer E, Speicher MR. Ulz P, et al. Among authors: zhou q. Nat Commun. 2020 Apr 20;11(1):1965. doi: 10.1038/s41467-020-15799-4. Nat Commun. 2020. PMID: 32313081 Free PMC article.
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity.
Koch C, Kuske A, Joosse SA, Yigit G, Sflomos G, Thaler S, Smit DJ, Werner S, Borgmann K, Gärtner S, Mossahebi Mohammadi P, Battista L, Cayrefourcq L, Altmüller J, Salinas-Riester G, Raithatha K, Zibat A, Goy Y, Ott L, Bartkowiak K, Tan TZ, Zhou Q, Speicher MR, Müller V, Gorges TM, Jücker M, Thiery JP, Brisken C, Riethdorf S, Alix-Panabières C, Pantel K. Koch C, et al. Among authors: zhou q. EMBO Mol Med. 2020 Sep 7;12(9):e11908. doi: 10.15252/emmm.201911908. Epub 2020 Jul 15. EMBO Mol Med. 2020. PMID: 32667137 Free PMC article.
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Unseld M, Belic J, Pierer K, Zhou Q, Moser T, Bauer R, Piringer G, Gerger A, Siebenhüner A, Speicher M, Heitzer E, Prager GW. Unseld M, et al. Among authors: zhou q. Int J Cancer. 2021 Mar 15;148(6):1452-1461. doi: 10.1002/ijc.33303. Epub 2020 Oct 16. Int J Cancer. 2021. PMID: 32949150 Free PMC article. Clinical Trial.
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
Perakis SO, Weber S, Zhou Q, Graf R, Hojas S, Riedl JM, Gerger A, Dandachi N, Balic M, Hoefler G, Schuuring E, Groen HJM, Geigl JB, Heitzer E, Speicher MR. Perakis SO, et al. Among authors: zhou q. ESMO Open. 2020 Sep;5(5):e000872. doi: 10.1136/esmoopen-2020-000872. ESMO Open. 2020. PMID: 32967919 Free PMC article.
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
Moser T, Waldispuehl-Geigl J, Belic J, Weber S, Zhou Q, Hasenleithner SO, Graf R, Terzic JA, Posch F, Sill H, Lax S, Kashofer K, Hoefler G, Schoellnast H, Heitzer E, Geigl JB, Bauernhofer T, Speicher MR. Moser T, et al. Among authors: zhou q. NPJ Precis Oncol. 2020 Nov 13;4(1):30. doi: 10.1038/s41698-020-00134-3. NPJ Precis Oncol. 2020. PMID: 33299124 Free PMC article.
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Suppan C, Graf R, Jahn S, Zhou Q, Klocker EV, Bartsch R, Terbuch A, Kashofer K, Regitnig P, Lindenmann J, Posch F, Gerritsmann H, Jost PJ, Heitzer E, Dandachi N, Balic M. Suppan C, et al. Among authors: zhou q. Br J Cancer. 2022 Feb;126(3):456-463. doi: 10.1038/s41416-021-01601-9. Epub 2021 Nov 9. Br J Cancer. 2022. PMID: 34754095 Free PMC article.
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Zhou Q, Gampenrieder SP, Frantal S, Rinnerthaler G, Singer CF, Egle D, Pfeiler G, Bartsch R, Wette V, Pichler A, Petru E, Dubsky PC, Bago-Horvath Z, Fesl C, Rudas M, Ståhlberg A, Graf R, Weber S, Dandachi N, Filipits M, Gnant M, Balic M, Heitzer E. Zhou Q, et al. Clin Cancer Res. 2022 Feb 15;28(4):697-707. doi: 10.1158/1078-0432.CCR-21-3231. Clin Cancer Res. 2022. PMID: 34862246 Free PMC article.
20,748 results
You have reached the last available page of results. Please see the User Guide for more information.